24/7 Wall St.
What Do You Need To Invest To Replace Your $95k Salary Just On Dividends Alone?
📊
AI Sentiment
Positive
6/10
- Home
- UNH
as of 03-17-2026 3:39pm EST
$286.77
+$1.27
+0.45%
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
| Founded: | 1977 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | 264.5B | IPO Year: | 2010 |
| Target Price: | $387.79 | AVG Volume (30 days): | 6.0M |
| Analyst Decision: | Buy | Number of Analysts: | 25 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 13.23 | EPS Growth: | -14.70 |
| 52 Week Low/High: | $234.60 - $606.36 | Next Earning Date: | 04-29-2026 |
| Revenue: | $447,567,000,000 | Revenue Growth: | 11.81% |
| Revenue Growth (this year): | -0.46% | Revenue Growth (next year): | 3.31% |
| P/E Ratio: | 21.71 | Index: | |
| Free Cash Flow: | 16.1B | FCF Growth: | -22.36% |
AI-Powered UNH Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 74.85%
74.85%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Jan 27, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYJan 27, 2026 · 100% conf.
AI Prediction BUY
1D
+1.97%
$288.32
Act: +3.32%
5D
+3.52%
$292.70
Act: +0.16%
20D
+5.83%
$299.23
Act: +0.43%
Price: $282.76 Prob +5D: 100% AUC: 1.000
0000731766-26-000025
unh-202601270000731766false00007317662026-01-272026-01-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 —————————————
FORM 8-K
————————————— Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 27, 2026 —————————————
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter) —————————————
Delaware1-1086441-1321939 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
1 Health Drive655 New York Avenue NW Eden Prairie,Minnesota55344Washington,DC20001 (Address of principal executive offices)(Zip Code)(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (800) 328-5979 N/A (Former name or former address, if changed since last report.) ————————————— Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $.01 par valueUNHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On January 27, 2026, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its fourth quarter and full year 2025 results. A copy of the press release is furnished herewith as Exhibit 99.1. The press release also includes a hyperlink to a pdf document which is furnished herewith as Exhibit 99.2. Exhibits 99.1 and 99.2 are incorporated herein by reference.
The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits.
ExhibitDescription 99.1 Press Release dated January 27, 2026
99.2 Hyperlinked PDF
104Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 27, 2026
UNITEDHEALTH GROUP INCORPORATED
By: /s/ Kuai H. Leong
Kuai H. Leong Senior Deputy General Counsel and Deputy Corporate Secretary
2025 Q3 Q3 2025 Earnings
8-K Oct 28, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 28, 2025
0000731766-25-000301
unh-202510280000731766false00007317662025-10-282025-10-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 —————————————
FORM 8-K
————————————— Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 28, 2025 —————————————
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter) —————————————
Delaware1-1086441-1321939 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
1 Health Drive655 New York Avenue NW Eden Prairie,Minnesota55344Washington,DC20001 (Address of principal executive offices)(Zip Code)(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (800) 328-5979 N/A (Former name or former address, if changed since last report.) ————————————— Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $.01 par valueUNHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 28, 2025, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its third quarter 2025 results. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits.
ExhibitDescription 99.1 Press Release dated October 28, 2025
104Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 28, 2025
UNITEDHEALTH GROUP INCORPORATED
By: /s/ Kuai H. Leong
Kuai H. Leong Senior Deputy General Counsel and Deputy Corporate Secretary
2025 Q2 Q2 2025 Earnings
8-K Jul 29, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 29, 2025
0000731766-25-000228
unh-202507290000731766false00007317662025-07-292025-07-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 —————————————
FORM 8-K
————————————— Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2025 —————————————
UNITEDHEALTH GROUP INCORPORATED
(Exact name of registrant as specified in its charter) —————————————
Delaware1-1086441-1321939 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
1 Health Drive655 New York Avenue NW Eden Prairie,Minnesota55344Washington,DC20001 (Address of principal executive offices)(Zip Code)(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (800) 328-5979 N/A (Former name or former address, if changed since last report.) ————————————— Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, $.01 par valueUNHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On July 29, 2025, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing its second quarter 2025 results. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits.
ExhibitDescription 99.1 Press Release dated July 29, 2025
104Cover Page Interactive Data File (formatted as Inline XBRL).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 29, 2025
UNITEDHEALTH GROUP INCORPORATED
By: /s/ Kuai H. Leong
Kuai H. Leong Senior Deputy General Counsel and Deputy Corporate Secretary
Latest UnitedHealth Group News
UNH Breaking Stock News: Dive into UNH Ticker-Specific Updates for Smart Investing
Simply Wall St.
How Leadership Shifts and Margin Repair Efforts At UnitedHealth Group (UNH) Has Changed Its Investment Story
➖
AI Sentiment
Neutral
4/10
Business Wire
UnitedHealthcare Expands Doula Offering to Employer-Sponsored Plans Nationwide
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Is UnitedHealth Group Incorporated (UNH) A Good Stock To Buy Now?
📊
AI Sentiment
Positive
6/10
Benzinga
Seniors Overpaid Medicare Premiums By $13.4B In 2025. That's About $212 For Every Enrollee, Joint Economic Committee Estimates
📉
AI Sentiment
Negative
3/10
Zacks
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
➖
AI Sentiment
Neutral
5/10
Simply Wall St.
Is UnitedHealth Group (UNH) Pricing Reflect Sector Pressures After A 39% Share Price Decline
📊
AI Sentiment
Positive
6/10
Benzinga
Trump Ally, New DHS Leader Nominee Markwayne Mullin Makes New Stock Trades: Here's What He Bought And Sold
➖
AI Sentiment
Neutral
5/10
Compare UNH vs Leading Stocks
See how UNH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "UNH UnitedHealth Group - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.